Review Study: A Retrospective Noninterventional Study to Assess the EffectiVeness of exIsting Anti-vascular Endothelial groWth Factor (Anti-VEGF) Treatment Regimens in Patients With Wet Age-related Macular Degeneration
Latest Information Update: 06 Nov 2021
At a glance
- Drugs Ranibizumab (Primary)
 - Indications Wet age-related macular degeneration
 - Focus Therapeutic Use
 - Acronyms REVIEW
 - Sponsors Bayer
 
Most Recent Events
- 06 Jun 2015 New trial record